# Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

> **NCT00789555** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 1260 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Olopatadine hydrochloride 0.6% nasal spray (PATANASE)
- **OTHER:** Olopatadine nasal spray vehicle, pH 3.7
- **OTHER:** Olopatadine nasal spray vehicle, pH 7.0

## Key facts

- **NCT ID:** NCT00789555
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 1260 (ACTUAL)
- **Last updated:** 2018-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789555, "Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00789555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*